RNA
Avidity Biosciences Inc
$24.13
Earnings Summary
Revenue | $2.19Mn |
Net Profits | $-60.44Mn |
Net Profit Margins | -2756.18% |
Highlights
Avidity Biosciences Inc’s revenue fell -20.8% since last year same period to $2.19Mn in the Q4 2023. On a quarterly growth basis, Avidity Biosciences Inc has generated -22.18% fall in its revenue since last 3-months.
Avidity Biosciences Inc’s net profit fell -26.67% since last year same period to $-60.44Mn in the Q4 2023. On a quarterly growth basis, Avidity Biosciences Inc has generated -15.44% fall in its net profits since last 3-months.
Avidity Biosciences Inc’s net profit margin fell -59.94% since last year same period to -2756.18% in the Q4 2023. On a quarterly growth basis, Avidity Biosciences Inc has generated -48.34% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Avidity Biosciences Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.78 |
EPS Estimate Current Year | -0.78 |
Highlights
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.78 - a -18.18% fall from last quarter’s estimates.
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.78.
Key Ratios
Key ratios of the Avidity Biosciences Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.79 |
Highlights
Avidity Biosciences Inc’s earning per share (EPS) jumped 10.23% since last year same period to -0.79 in the Q4 2023. This indicates that the Avidity Biosciences Inc has generated 10.23% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-28 | -0.66 | -0.79 | -19.7% |
2023-08-08 | -0.8 | -0.66 | 17.5% |
2023-11-08 | -0.77 | -0.71 | 7.79% |
2023-05-09 | -0.85 | -0.74 | 12.94% |
₹0 US Stocks a/c Opening Fee